Use of the Afirma Xpression Atlas for cytologically indeterminate, Afirma Genomic Sequencing Classifier suspicious thyroid nodules: Clinicopathologic analysis with postoperative molecular testing.

Carlos A Munoz-ZuluagaJonas J HeymannJames P SolomonAmi PatelMomin T SiddiquiTheresa ScognamiglioHamza Numan Gokozan

Published in: American journal of clinical pathology (2023)

Afirma XA improved risk stratification of thyroid disease with a high risk of malignancy in Afirma GSC suspicious nodules. A negative Afirma XA result, however, should not be used as a rule-out test.

Keyphrases

single cell
patients undergoing
gene expression
dna methylation
single molecule
neural network